These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20055562)

  • 1. Current issues in the histopathology of gestational trophoblastic tumors.
    Sebire NJ; Lindsay I
    Fetal Pediatr Pathol; 2010; 29(1):30-44. PubMed ID: 20055562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
    Sebire NJ
    Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
    Sebire NJ; Fisher RA; Williams S; Prendergast G; Savage P; Seckl M
    J Reprod Med; 2008 Oct; 53(10):789-92. PubMed ID: 19004406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathology of gestational trophoblastic disease: recent advances.
    Wells M
    Pathology; 2007 Feb; 39(1):88-96. PubMed ID: 17365825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of gestational trophoblastic diseases.
    Berkowitz RS; Goldstein DP
    Gynecol Oncol; 2009 Mar; 112(3):654-62. PubMed ID: 18851873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53.
    Soper JT; Mutch DG; Schink JC;
    Gynecol Oncol; 2004 Jun; 93(3):575-85. PubMed ID: 15196847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic disease in 2005.
    Therasakvichya S
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S119-23. PubMed ID: 17722325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant trophoblastic tumors (MTT) treated in the years 1955-2004 in trophoblastic disease center in the Czech Republic (TDC-CZ): clinical-pathological features, curability, typing, pathogenesis].
    Zavadil M; Feyereisl J; Safár P; Pán M
    Ceska Gynekol; 2004 Dec; 69 Suppl 1():9-15. PubMed ID: 15748020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of gestational trophoblastic neoplasia.
    Horowitz NS; Goldstein DP; Berkowitz RS
    Semin Oncol; 2009 Apr; 36(2):181-9. PubMed ID: 19332252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choriocarcinoma and gestational trophoblastic disease.
    Smith HO; Kohorn E; Cole LA
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):661-84. PubMed ID: 16310678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of gestational trophoblastic neoplasia.
    Goldstein DP; Berkowitz RS
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):111-31. PubMed ID: 22244665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of gestational trophoblastic disease (GTD).
    Kaur B
    Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():3-28. PubMed ID: 34219021
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.